Loading...
Development of skin hypopigmentation in a patient with metastatic papillary carcinoma thyroid treated with Sorafenib
BACKGROUND: Sorafenib can be considered as the effective option of treatment in patients with metastatic radioiodine refractory differentiated thyroid cancers. The cutaneous manifestations of Sorafenib include rash, desquamation, hand foot skin reactions, pruritus, alopecia and erythema. We report t...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3750499/ https://ncbi.nlm.nih.gov/pubmed/23937803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6823-13-29 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|